Abstract
The conventional treatment for both rectal and anal carcinomas remains surgery, with a characteristic 5-year survival rate of approximately 50% at each disease site (Enbald and Adami 1988). The role of radiation therapy in the management of these diseases was not recognized until fairly recently; initially radiation therapy played a palliative role but was not regarded with favor as either a definitive or an adjunct modality. Early suboptimal equipment and poor quality of delivery, coupled with disappointing results and significant morbidity, caused surgeons to remain antagonistic. Once supervoltage irradiation became available, results improved and it was possible to treat patients to tumoricidal doses within normal tissue tolerance dose levels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balslev IB, Pederson M, Teglbjaerg PS et al. (1986) Postoperative radiotherapy in Dukes’ B and C carcinoma of the rectum and rectosigmoid: a randomized study. Cancer 58: 22–28
Bethune WA (1987) Carcinoma of the rectum: 508 patients with failure analysis and implication of adjuvant therapy. J Can Assoc Radiol 38: 209–216
Butcher HR Jr (1971) Carcinoma of the rectum — a choice between an anterior resection and abdomino-perineal resection of the rectum. Cancer 28: 204–207
Byfield JE, Barone R, Medelson J et al. (1980) Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancer. Cancer 45: 703–708
Byfield JE, Frankel SS, Hornbeck CL et al. (1985) Phase 1 and pharmacologic study of 72-hour infused 5- fluorouracil in man. Am J Clin Oncol 8: 429–440
Courtail J, Fenadez Colmeiro JM (1960) Les indications et les résultats de la roentgentherapie et al curie dans le cancer du canal anal. Arch Mal Appar Dig Suppl 49: 43–54
Doggett SW, Green JP, Cantril ST (1988) Efficacy of radiation therapy alone for limited squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 15: 1069–1072
Douglass HO Jr, Moertel CG (1986) Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315: 1294
Enbald P, Adami HO (1988) Improved survival of patients with cancers of the colon and rectum? JNCI 80: 586–591
Fisher B, Woolmark N, Rockette H et al. (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. JNCI 80: 21–29
Friedmann P, Garb JL, Park WC et al. (1985) Survival following moderate-dose preoperative radiation therapy of carcinoma of the rectum. Cancer 55: 967–973
Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312: 1465–1472
Gérard A, Buyse M, Nordlinger B et al. (1988) Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization of Research and Treatment of Cancer (EORTC). Ann Surg 208: 60–64
Gunderson LL, Sosin H (1974) Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 34: 1278–1292
Haghbin M, Sischy B, Hinson EJ (1988) Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma. Radiother Oncol 13: 75–81
Heidelberger C, Griesbach L, Montago BJ et al. (1958) Studies on fluorinated pyrimidines. 11. Effects on transplanted tumors. Cancer Res 18: 305–317
Learning RH, Stearns MW Jr, Deddish MR (1961) Preoperative irradiation in rectal carcinoma. Radiology 77: 257–263
Lokich JJ (1985) Optimal schedule for 5-fluorouracil chemotherapy. Intermittent bolus of continuous infusion? Am J Clin Oncol 8: 445–448
Looney WB, Hopkins HA, MacLeod MS et al. (1979) Solid tumor models for the assessment of different treatment modalities. XII. Combined chemotherapy-radiotherapy: variation of time interval between time of administration of 5-fluorouracil and radiation and its effect on the control of tumor growth. Cancer 44: 437–445
Myers CE, Diasio R, Elliot HM et al. (1976) Pharmacokinetics of the fluoropyrimidines: implication for their use. Cancer Treat Rev 3: 175–183
Nakajima Y, Miyamoto T, Tanake M et al. (1979) En-hancement of mammalian cell killing by 5-fluorouracil in combination with x-rays. Cancer Res 39: 3736–3637
Nigro N, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17: 354–356
Páhman L, Glimelius B, Graffman S (1986) Pre- versus postoperative radiotherapy in rectal carcinoma: an interim report from a randomized multicentre trial. Br J Surg 72: 961–966
Peters RK, Mack TM, Berstein L (1984) Parallels in the epidemiology of selected anogenital carcinomas. JNCI 72: 609–615
Rao AR, Dagan AR, Chan PM et al. (1981) Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer 48: 1492–1495
Rockwell S (1982) Cytotoxicities of mitomycin C and x-rays to íerobic and hypoxic cells in vitro. Int J Radiat Oncol B 3l Phys 8: 1035–1039
Roswit B, Higgins CA, Park WC et al. (1975) Preoperative radiation for carcinoma of the rectum and rectosigmoid. Cancer 35: 1597–1602
Roux-Berger JL, Ennuyer A (1948) Carcinoma of the anal canal; Statistic Foundation Curie. AJR 60: 807–815
Sischy B (1985) The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 11: 1587–1593
Sishcy B, Remington JH, Sobel SH et al. (1980) Treatment of carcinoma of the rectum and squamous cell carcinoma of the anus by combination chemotherapy, radiotherapy and operation. Surg Gynecol Obstet 151: 369–371
Sischy B, Doggett RLS, Krall JM et al. (1989) JNCI 81: 850–856
Slater G, Greenstein A, Aufses AH Jr (1984) Anal carcinoma in patients with Crohn’s disease. Ann Surg 199: 348–350
Spremullt EN, Leith JT, Bliven SF et al. (1983) Response of a human colon adenocarcinoma (DLD-I) to x- irradiation and mitomycin C in vitro. Int J Radiat Oncol Biol Phys 9: 1209–1212
Sweet RH (1947) Results of treatment of epidermoid carcinoma of the anus and rectum. Surg Gynecol Obstet 84: 967–972
Vietti T, Enggerding R, Valeriote F (1971) Combined effect of x-radiation and 5-fluorouracil on survival of transplanted leukemic cells. JNCI 47: 865–870
Vigilotti A, Rich TA, Romsdahl MM et al. (1987) Postoperative adjuvant radiotherapy for adenocarcinoma of the rectum and recto-sigmoid. Int J Radiat Oncol Biol Phys 13: 999–1006
Vogelzang NJ (1984) Continuous infusion chemotherapy: a critical review. J Clin Oncol 2: 1289–1304
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sischy, B. (1991). Efficacy of 5-Fluorouracil by Continuous Infusion as a Radiopotentiator — Anal and Rectal Carcinoma. In: Rotman, M., Rosenthal, C.J. (eds) Concomitant Continuous Infusion Chemotherapy and Radiation. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84186-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-84186-6_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84188-0
Online ISBN: 978-3-642-84186-6
eBook Packages: Springer Book Archive